The Group's principal activities are the development, production and marketing of products for dental implants and biomaterials for soft and hard tissue generation. Together with research scientists and clinics, the Group develops and produces implants, prosthetic parts, instruments, and biomaterials for implant dentistry and markets them worldwide. The products and services of the Group enable to treat patients successfully and to increase their quality of life substantially. The Group operates in Europe, North America and Asia/Pacific.
Alacra Alerts:
Receive alerts on the latest reports on Straumann Holding AG
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
